Seite drucken
Publikationen  / 2012

Publikationen 2012 (in alphabetischer Reihenfolge)

 

Members (PIs) of CRC 685 are underlined

 

Braumüller H, Wieder T, Brenner E, Aßmann S, Fischer S, Hahn M,, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier, F, van den Broek M, Häring HU, Handgretinger R, Quintilla-Fend L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Röcken M. TH1 Cell Cytokines Drive Cancer into Senescence. Nature. In press (2012).

 

 

Icheva V, Kayser S, Wolff D, Tuve S, Kyzirakos C, Bethge W, Greil J, Albert MH, Schwinger W, Nathrath M, Schumm M, Stevanovic S, Lang P, Handgretinger R, Feuchtinger T. Adoptive transfer of EBNA1-specific T cells as a treatment of Epstein-Barr-Virus reactivation and lymphoproliferative disorders following allogeneic stem cell transplantation. Journal of Clinical Oncology, 2012, in press.

 

Feldhahn M, Dönnes P, Schubert B, Schilbach K, Rammensee H-G, Kohlbacher O. miHA‐Match: computational detection of tissue‐specific minor histocompatibility antigens. J. Immunol. Meth. 2012, accepted.

 

Schuster M, Glauben R, Schreiber L, Annemann M, Floess S, Kühl AA, Clayton LK, Sparwasser T, Schulze-Osthoff K, Pfeffer K, Huehn J, Siegmund B, Schmitz I. The atypical NFΚκB inhibitor IκBNS controls development of regulatory T cells. Immunity 2012; in press

 

-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

André MC, Gille C, Glemser P, Woiterski J, Hsu HY, Spring B, Keppeler H, Kramer BW, Handgretinger R, Poets CF, Lauber K, Orlikowsky TW: Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses. J Leukoc Biol 91(6):977-89; 2012. PubMed

 

Autenrieth SE, Warnke P, Wabnitz GH, Lucero Estrada C, Pasquevich KA, Drechsler D, Günter M, Hochweller K, Novakovic A, Beer-Hammer S, Samstag Y, Hämmerling GJ, Garbi N, Autenrieth IB. Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis. PLoS Pathog 8(2):e1002552; 2012. PubMed

 

Bantel H, Schulze-Osthoff K. TNF antagonists in IBD: Novel antiinflammatory mechanisms beyond cytokine inhibition. Inflamm Bowel Dis; 2012. [Epub ahead of print]. Opens external link in new windowPubMed

 

Bloes DA, Otto M, Peschel A, Kretschmer D. Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2. PLoS One 7(6):e39910; 2012. PubMed

 

Essmann F, Schulze-Osthoff K. Translational approaches targeting the p53 pathway for anti-cancer therapy. Br J Pharmacol 165(2):328-44; 2012. Opens external link in new windowPubMed

 

Hilpert J, Grosse-Hovest L, Grünebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR. Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses. J Immunol 189(3):1360-71; 2012. PubMed



Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm A, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G. Generation, selection and preclinical characterization of an Fc-optimized FLT3-antibody for the treatment of myeloid leukemia. Leukemia 26(6) 28-37; 2012. PubMed

 

Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, Manns MP, Schulze-Osthoff K, Bantel H. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 55(2):455-64; 2012. Opens external link in new windowPubMed

 

Kaesler S, Sobiesiak M, Kneilling M, Volz T, Kempf W, Lang P, Lang K, Wieder T, Heller-Stilb B, Warskulat U, Häussinger D, Lang F, Biedermann T. Effective T cell recall responses require the taurine transporter Taut. Eur J Immunol 42(4):831-41; 2012. PubMed

 

 

Köberle M, Kaesler S, Kempf W, Wölbing F, Biedermann T. Tetraspanins in mast cells. Front Immunol 3:106; 2012. PubMed

 

Konantz M, André MC, Ebinger M, Grauer M, Wang H, Grzywna S, Rothfuss OC, Lehle S, Kustikova OS, Salih HR, Handgretinger R, Fend F, Baum C, Kanz L, Quintanilla-Martinez L, Schulze-Osthoff K, Essmann F, Lengerke C. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia; 2012.[Epub ahead of print]. Opens external link in new windowPubMed

 

Koslowski MJ, Teltschik Z, Beisner J, Schaeffeler E, Wang G, Kübler I, Gersemann M, Cooney R, Jewell D, Reinisch W, Vermeire S, Rutgeerts P, Schwab M, Stange EF, Wehkamp J. Association of a Functional Variant in the Wnt Co-Receptor LRP6 with Early Onset Ileal Crohn's Disease. PLoS Genet 8(2):e1002523; 2012. Opens external link in new windowPubMed

 

Lauber K, Ernst A, Orth M, Herrmann M, Belka C. Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front Oncol 2:116; 2012. Opens external link in new windowPubMed

 

Leibold J, Feucht J, Halder A, Stevanovic S, Kayser S, Handgretinger R, Feuchtinger T. Induction of THELPER1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers. J Immunother 35(9):661-9; 2012. Opens external link in new windowPubMed

 

Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T. Structures of Merkel Cell Polyomavirus VP1 Complexes Define a Sialic Acid Binding Site Required for Infection. PLoS Pathog 8(7):e1002738; 2012. Opens external link in new windowPubMed

 

Peter C, Waibel M, Keppler H, Lehmann R., Xu G, Halama A, Adamski J, Schulze-Osthoff K, Wesselborg S, Lauber K. Release of lysophospholipid ‘find-me’ signals during apoptosis requires the ATP-binding cassette transporter A1. Autoimmunity 45(8):568-73; 2012 PubMed

 

Pfeiffer MM, Schumm M, Müller I, Handgretinger R, Lang P. IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT. Leukemia 2012. [Epub ahead of print]. Opens external link in new windowPubMed

 

Placke T, *Salih HR, *Kopp HG. GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity. J Immunol 189(1):154-60; 2012. *equal contribution. PubMed

Placke T, Örgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, Salih HR. Platelet-derived MHC Class I confers a pseudo-normal phenotype to cancer cells that subverts the anti-tumor reactivity of natural killer immune cells. Cancer Res. 72:440-8; 2012. PubMed

Schwarzbich MA, Gutknecht M, Salih J, Salih HR, Brossart P, Rittig SM, Grünebach F. The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors. Cancer Immunol Immun 61:193-202; 2012. PubMed

 

 

Stoeckle C, Quecke P, Rückrich T, Burster T, Reich M, Weber E, Kalbacher H, Driessen C, Melms A, Tolosa E. Cathepsin S dominates autoantigen processing in human thymic dendritic cells. J Autoimmun 38(4):332-43, 2012. Opens external link in new windowPubMed

 

Teml A, Schaeffeler E, Karner S, Schwab M. Pharmacogenomics of Inflammatory Bowel Diseases. In: Maitland-van der Zee AH, Daly AK (eds.). Pharmacogenomics and Individualized Therapy. John Wiley & Sons Inc. 2012.

 

Volz T, Kaesler S, Biedermann T. Innate immune sensing 2.0 - from linear activation pathways to fine tuned and regulated innate immune networks. Exp Dermatol 21(1):61-9; 2012. PubMed

 

Wahl K, Siegemund M, Lehner F, Vondran F, Nüssler A, Länger F, Krech T, Kontermann R, Manns MP, Schulze-Osthoff K, Pfizenmaier K, Bantel H. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib. Hepatology; 2012. [Epub ahead of print]. Opens external link in new windowPubMed

 

Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C, Singh-Jasuja H. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012 Jul 29. [Epub ahead of print]. PubMed

 

Widenmeyer M, Griesemann H, Stevanović S, Feyerabend S, Klein R, Attig S, Hennenlotter J, Wernet D, Kuprash DV, Sazykin AY, Pascolo S, Stenzl A, Gouttefangeas C, Rammensee HG. Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. Int J Cancer 131(1):140-9; 2012. PubMed

 

 

Members (PIs) of CRC 685 are underlined

 

Keine News in dieser Ansicht.

   Werbeagentur: | www.dipool.net